Navigation Links
Celladon Corporation Named a 2012 Fierce 15 Company by FierceBiotech
Date:9/19/2012

SAN DIEGO, Sept. 19, 2012 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that FierceBiotech named Celladon as one of 2012's Fierce 15, designating it as one of the most promising private biotechnology companies in the industry. This is FierceBiotech's tenth annual Fierce 15 selection.

"You don't often find three Big Pharmas clustered together in a single venture round earmarked for a mid-stage heart-failure drug. But there they were – Pfizer, Novartis and Johnson & Johnson – all backing Celladon's big $53 million round earlier this year," says FierceBiotech Editor John Carroll. "And once you check out the positive mid-stage efficacy data for Celladon's innovative new gene therapy MYDICAR – now being tested in an expanded Phase IIb confirmatory study – you can see for yourself why they'd want a front-row seat. We'll be watching as well."

"We are proud to join this prestigious group of innovative companies and for our team's recognition as a Fierce 15 Company. There is a tremendous need for novel treatment options for patients with advanced heart failure. The Celladon team is working passionately to provide patients with this debilitating condition with a new therapeutic alternative," said Krisztina Zsebo Ph.D., President and CEO of Celladon Corporation. "Together with our investors, we are also grateful to the clinical investigators and patients who participate in novel trials and thereby make advances in medicine possible."

The Fierce 15 celebrates the spirit of being "fierce" – championing innovation and creativity, even in the face of intense competition.

An internationally recognized daily newsletter reaching more than 100,000 biotech and pharma industry professionals, FierceBiotech provides subscribers with an authoritative analysis of the day's top stories. Every year
'/>"/>

SOURCE Celladon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
2. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
3. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
4. Neogen Corporation Announces 2nd Quarter Results Conference Call
5. Luminex Corporation to Present at JP Morgan Healthcare Conference
6. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
7. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
8. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
9. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
10. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
11. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  LABSCO, the leading ... products to hospitals, physician office laboratories and alternate ... October 1, 2014, it will serve as Siemens ... market segments and as a semi-exclusive sales distributor ... contiguous United States . LABSCO ...
(Date:9/16/2014)... 2014 BCC Research reveals in ... CELLS , the global market for stem cells is ... with a five-year compound annual growth rate (CAGR) of ... Americas with growth projections of $2.2 billion in 2014 ... http://photos.prnewswire.com/prnh/20140805/700528) , Unlike other potential applications of ...
(Date:9/15/2014)... 15, 2014   Global Science & Technology, ... products and services for satellite and weather systems, ... Integrated Services (OASIS) from the General Services Administration ... to provide the government best-value solutions for complex ... category in Pool 4. The OASIS SB award ...
(Date:9/15/2014)... from North Carolina State University have developed a technique ... applying very low voltages, opening the door to a ... technologies. The technique hinges on the fact that the ... deposited or removed acts as a surfactant, lowering ... fluid. , The researchers used a liquid metal alloy ...
Breaking Biology Technology:LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Researchers control surface tension to manipulate liquid metals 2
... Jan. 19, 2012  SynCardia Systems, Inc. ( www.syncardia.com ... Heart, announced today that on Dec. 29, 2011, ... Total Artificial Heart patient, 61-year-old Nikola Gaspic, to ... using the Freedom® portable driver . ...
... -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... that specializes in patented biopharmaceutical medicine, modernized ... active pharmaceutical ingredients (API) announced the Company ... certification for its 250-ton Jiangchuan Macrolide Facility ...
...  Synthetic Genomics Inc. (SGI), a privately held company commercializing ... of global challenges, today announced they have hired George ... is a proven leader with experience in developing sophisticated ... and nutritional products for humans and animals. At SGI ...
Cached Biology Technology:Slovenia's 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the FreedomĀ® Portable Driver 2Slovenia's 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the FreedomĀ® Portable Driver 3TPI Receives GMP Certification for JCM Facility 2TPI Receives GMP Certification for JCM Facility 3Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program 2
(Date:9/16/2014)... The risk of severe maternal morbidity amongst women ... suggests a new study published today (17 September) ... and Gynaecology . , Australians generally enjoy high ... that health disparities exist, in particular between indigenous ... aimed to explore the independent impact of socioeconomic ...
(Date:9/16/2014)... YORK (17 September, 2014)More than $100 trillion in ... of annual carbon dioxide (CO2)a 40 percent reduction ... 2050 if the world expands public transportation, walking ... report released by the University of California, Davis, ... (ITDP). , Further, an estimated 1.4 million ...
(Date:9/16/2014)... Pit Fire began on September 13, 2014. The fire ... is currently over 2,300 acres in size and is mostly ... Pit Fire was calm Monday night due to higher humidity. ... anchor point and beginning to construct a fireline on the ... resources are working on the fire: , 7 20-person Crews, ...
Breaking Biology News(10 mins):New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5
... Obese women are as much as 28 percent ... pregnancy, according to research that earned a Michigan State ... Barbara Luke, a researcher in the MSU College of ... focused on data of nearly 50,000 women using assisted ...
... the UCLA Henry Samueli School of Engineering and Applied ... the laboratory the enzyme responsible for producing the blockbuster ... published Oct. 23 in the journal Science , ... with similarly beneficial effects. The ...
... at Chicago have received $1 million from the National ... between "fat taxes" and food consumption, diet quality and ... made available through the American Recovery and Reinvestment Act ... rates associated with restaurants and with specific sugar- and ...
Cached Biology News:MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2
... SDSaway reagent is a valuable tool for ... The presence of SDS in biological samples ... bound SDS-protein complex, inhibits enzymatic activity during ... as a contaminant in mass spectrometry analyses. ...
... cGMP Safe Deposit Service ECACC is able ... requirements of cGMP for cryo-storage. The cell lines ... they have been produced in accordance with the ... tested for freedom from mycoplasma, bacteria or fungi. ...
Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....
... has 20 years of expertise in the ... still offers the most powerful systems on ... to 40 000 in-microplate tests requiring incubation ... of different modules (such as worktable shaker ...
Biology Products: